-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on AEON Biopharma, Raises Price Target to $2

Benzinga·10/01/2026 16:12:43
Lake Street analyst Thomas Flaten maintains AEON Biopharma (AMEX:AEON) with a Buy and raises the price target from $1 to $2.